Trial · NCT06542393
Registered outcomes14
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 14 of 14
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Mean number of units of Red Blood Cells (RBC) | Until perioperative day 3 | Compare the need of blood transfusion in the perioperative period |
| Secondary | Length of ICU stay | From time of admission after surgery to time of clinical conditions of discharge (time of ICU medical discharge, not time of ICU room exit). Up to 240 hours. | Hours |
| Secondary | Length of hospital stay | From time of ICU medical discharge until time of Hospital discharge (Up to 14 days). | Days |
| Secondary | Length of mechanical ventilation | From time of intubation by anesthesia team until time of extubation by ICU team (Up to 240 hours). | Hours |
| Secondary | Need of Dyalisis (Acute Kidney Disease) | Based on KDIGO classification of Acute Kdney Injury, level III of the classification. (Up to 120 hours from ICU admission, accountable from the time Dyalisis is indicated). | Needing of dyalisis in peoperative period |
| Secondary | Perioperative infection | Until perioperative day 3 | Anytype |
| Secondary | Bleeding | From time of admission on ICU until hour 24th after admission (accountable amount from how many chest tubes the patient was admitted). | Thorax drain tubes bleeding (ml) |
| Secondary | Epigenetics alterations | Until perioperative day 3 | . Differentially methylated regions (DMRs) and differentially methylated loci (DMLs) will be considered to determine if these regions are hypermethylated or hypomethylated in the comparison between groups. |
| Secondary | Inflammatory response | Until perioperative day 3 | A total of 25 μl of serum per patient will be used for the detection of the following analytes: IL-1β, IL-6, IL-10, TNF-α, CRP, and NT-ProBNP. |
| Secondary | Perioperative myocardial infarction | Until perioperative day 3 | According to type 5 Myocardial ischemia |
| Secondary | Stroke | Until perioperative day 3 | Any level of neurological deficit |
| Secondary | Hemoglobin levels | Until perioperative day 3 and at discharge | Accountable in g/dl |
| Secondary | All-cause mortality | From day of the intervention (if intervention group) or from the moment of surgery (if control group) until day of hospital discharge (death from any cause accountable as in-hospital mortality). | Death from any cause accountable as in-hospital mortality |
| Secondary | Cardiovascular mortality | From day of the intervention (if intervention group) or from the moment of surgery (if control group) until day of hospital discharge (any cardiovascular reason as main cause of death accountable as in-hospital mortality).) | any cardiovascular reason as main cause of death accountable as in-hospital mortality |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT06542393/registered